|
|
Details: |
|
|
Related Sites |
|
Melanoma Research Foundation (Popularity: ): Dedicated to finding a cure, this non-profit also offers information and resources to patients, family and friends. Located in Lake ...
Melanoma Education Foundation (Popularity: ): Non-profit offers information on self-detection and prevention, patient stories, links and references. Located in Peabody, Massachusetts.
UK Melanoma Study Group (Popularity: ): London-based professional group for physicians and patients. Offers guidelines, meetings schedule and organizational overview.
The MOLE Clinic UK (Popularity: ): Details the work of an advanced screening facility for melanoma in London. Includes practical information about suspicious skin areas.
Interferon for Melanoma (Popularity: ): Provides some general information highlighting the possible role of a drug agent by the pharmaceutical firm Schering-Plough.
SkinLesions.net: Diagnosis of Melanoma (Popularity: ): Scientific site which highlights the use of computers in medicine.
Peter's Fund Racer (Popularity: ): Annual snow ski race in Warren, Vermont raises funds for melanoma research.
Learn Melanoma.org (Popularity: ): Learn how to improve early detection of suspicious moles.
SHADE Foundation.org (Popularity: ): The mission of the Curt and Shonda Schilling Melanoma Foundation is to reduce melanoma through education and sun safety. Headquartered ...
|
|
Popular Sites |
|
SHADE Foundation.org (Popularity: ): The mission of the Curt and Shonda Schilling Melanoma Foundation is to reduce melanoma through education and sun safety. Headquartered ...
Learn Melanoma.org (Popularity: ): Learn how to improve early detection of suspicious moles.
Peter's Fund Racer (Popularity: ): Annual snow ski race in Warren, Vermont raises funds for melanoma research.
SkinLesions.net: Diagnosis of Melanoma (Popularity: ): Scientific site which highlights the use of computers in medicine.
Interferon for Melanoma (Popularity: ): Provides some general information highlighting the possible role of a drug agent by the pharmaceutical firm Schering-Plough.
|
|
Related Press |
|
|
Related Articles |
|
|
|